Atlas Brown’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$466K Sell
5,959
-505
-8% -$39.5K 0.15% 136
2025
Q1
$469K Hold
6,464
0.16% 130
2024
Q4
$479K Buy
6,464
+15
+0.2% +$1.11K 0.16% 124
2024
Q3
$426K Buy
6,449
+516
+9% +$34.1K 0.15% 135
2024
Q2
$548K Buy
5,933
+15
+0.3% +$1.39K 0.2% 113
2024
Q1
$566K Buy
5,918
+5
+0.1% +$478 0.21% 107
2023
Q4
$451K Hold
5,913
0.19% 119
2023
Q3
$410K Hold
5,913
0.19% 119
2023
Q2
$558K Hold
5,913
0.25% 105
2023
Q1
$489K Hold
5,913
0.23% 112
2022
Q4
$441K Hold
5,913
0.22% 118
2022
Q3
$489K Hold
5,913
0.25% 113
2022
Q2
$562K Hold
5,913
0.27% 107
2022
Q1
$696K Buy
5,913
+50
+0.9% +$5.89K 0.28% 107
2021
Q4
$760K Sell
5,863
-500
-8% -$64.8K 0.29% 102
2021
Q3
$720K Hold
6,363
0.31% 99
2021
Q2
$659K Hold
6,363
0.28% 102
2021
Q1
$532K Hold
6,363
0.25% 109
2020
Q4
$580K Hold
6,363
0.3% 98
2020
Q3
$508K Hold
6,363
0.3% 89
2020
Q2
$440K Buy
6,363
+363
+6% +$25.1K 0.28% 96
2020
Q1
$377K Hold
6,000
0.29% 96
2019
Q4
$467K Hold
6,000
0.29% 96
2019
Q3
$440K Hold
6,000
0.31% 94
2019
Q2
$369K Sell
6,000
-1,002
-14% -$61.6K 0.26% 102
2019
Q1
$447K Hold
7,002
0.32% 89
2018
Q4
$357K Hold
7,002
0.28% 91
2018
Q3
$406K Hold
7,002
0.25% 99
2018
Q2
$343K Sell
7,002
-552
-7% -$27K 0.08% 109
2018
Q1
$351K Sell
7,554
-642
-8% -$29.8K 0.06% 106
2017
Q4
$341K Sell
8,196
-96
-1% -$3.99K 0.06% 109
2017
Q3
$302K Buy
+8,292
New +$302K 0.06% 105